adding anthracyclines to the adjuvant treatment of breast cancer - data review and practical implica
Published 8 years ago • 46 plays • Length 6:27Download video MP4
Download video MP3
Similar videos
-
6:15
adding anthracyclines to the adjuvant treatment of breast cancer
-
5:22
adding anthracyclines for her2 disease
-
5:52
anthracyclines for her2-positive early breast cancer
-
30:56
adjuvant treatment for early stage hormone positive breast cancer: role of genomic signatures
-
5:42
adjuvant t-dm1 for her 2 breast cancer: critical data from the katherine study
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy
-
3:20
dr. hurvitz on eliminating anthracyclines in her2 breast cancer treatment
-
5:05
anti-her2 mechanisms of approved her2 inhibitors
-
10:08
how to manage fears of breast cancer recurrence
-
1:05:11
ask the expert: early-stage her2-positive breast cancer with adrienne waks, md
-
53:15
will new antibody drug conjugates cure bladder cancer?
-
13:56
adjuvant therapy - chemotherapy issues
-
5:32
esmo 2020 expert video report on cdk4 6i in the adjuvant treatment of breast cancer
-
2:02
chemotherapy with adjuvant therapy in breast cancer
-
1:07:43
new & supporting data for optimizing therapy in her2 breast cancer | dr. mahtani & dr. schwartzberg
-
4:11
the latest in neo-adjuvant therapy for luminal breast cancer
-
20:25
her2 early-stage breast cancer: peri-operative therapy
-
7:56
why aren't scans ordered after breast cancer treatment?
-
3:11
st. gallen consensus 2021: neoadjuvant and adjuvant therapy for her2 breast cancer
-
4:16
adjuvant treatment for stage i her2 breast cancer
-
7:15
pathologic complete response rates improved with the neoadjuvant and adjuvant treatment of pembr...
-
13:40
'it's an adc world': new breast cancer data from asco 2022